SERVA HEALTH
LIVE

Serial Number

87864722

Owner

SERVA HEALTH LLC

Attorney

John J. O'Malley

First Use Date

Nov 6, 2017

Filing Date

Apr 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SERVA HEALTH Trademark

Serial Number: 87864722 • Registration: 6341949

SERVA HEALTH is a trademark filed by SERVA HEALTH LLC on April 5, 2018. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SERVA HEALTH LLC (5 trademarks)

Suite 201
Mount Laurel, NJ 08054

Entity Type: 16

Trademark Details

Filing Date

April 5, 2018

Registration Date

May 4, 2021

First Use Anywhere

November 6, 2017

First Use in Commerce

November 6, 2017

Published for Opposition

June 16, 2020

Goods & Services

Providing case management and clinical services, namely, coordinating legal, medical, physical, social, personal care, and psychological services for children, adults, and elderly individuals; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; providing clinical research case management services, namely, coordination of medical services for others involving drugs and medical devices

Compiling data for research purposes in the field of medical science and medical consultancy; Data warehousing; Providing temporary use of online non-downloadable software for use in health information systems for receiving, processing, transmitting, and displaying data, controlling and managing patient health information, and medical and healthcare analytics; Providing temporary use of online non-downloadable software for use in hub services, namely, patient support services, pharmacy benefits investigation, medication orders, co-pay assistance, billing and account receivables, shipping and reporting, patient data aggregation and analysis, and call center services, placing and tracking prescription medication orders, tracking and analyzing patient clinical care outcomes; Providing temporary use of online non-downloadable software for use in customer relationship management (CRM); Providing temporary use of online non-downloadable software for providing call and contact center functions; Providing online computer databases and online searchable databases featuring medical and scientific research information in the field of clinical trials

Financial administration of patient reimbursement programs; Pharmaceutical and/or medical device benefit management services; Providing information in the field of health benefit plans, namely, providing benefits pre-screening services in the nature of providing health benefit information for clinical trials, pharmaceutical treatment, medical devices, and surgical procedures; Healthcare benefits investigation, namely, providing consultation in the field of healthcare benefits; Healthcare and pharmaceutical benefits verification, namely, insurance eligibility verification; Healthcare and pharmaceutical prior authorization services, namely, insurance eligibility review; Healthcare review services as they relate to prescription drugs, namely, insurance eligibility review and verification; Providing information about drug reimbursement for prescribers, patients, and the pharmaceutical industry by means of a call center; Claims administration services in the field of health insurance, namely, administration of healthcare assignment of benefits for others and verification of patient eligibility for health- and prescription-benefits coverage of pharmaceuticals

Pharmaceutical and/or medical device cost management for the healthcare benefit plans of others; Healthcare utilization and review services as they relate to prescription drugs, namely, pharmaceutical and/or medical device cost management, drug utilization review services, Business administration of pharmacy reimbursement programs and services, Business administration of patient reimbursement programs; Business consultation in the field of healthcare, pharmaceuticals, hospital pharmacy, specialty pharmacy, and medical devices; Cost management for the healthcare, pharmacy, and prescription drug benefit plans of others; Specialty pharmacy services, namely, data collection services in the nature of patient information intake to maintain and retain patients on medication and report data for business purposes; Compiling of information into computer databases; Patient relationship management services; Business management in the field of patient assistance programs, prescription drugs, and new specialty drugs; Management of telephone call centers for others; Operation of telephone call centers for others; Management and operation of telephone call centers for specialty pharmaceutical companies; Business consulting services for specialty pharmaceutical companies; Product complaint processing services for drugs and medical devices, namely, collection of complaint information from patients of adverse events and medical reactions to drugs or medical devices into computer databases and reporting data to drug or medical device manufacturer for business purposes; Customer services, namely, responding to inquiries from and reaching out to patients for others with respect to drugs and medical devices they are utilizing; Customer services, namely, responding to inquiries from and reaching out vendors providing clinical studies for others with respect to drugs and medical devices they are studying; Administrative processing of invoices; clinical research selection services, namely, selection and identification of clinical investigators and researchers for clinical studies; Recruiting and enrolling patients for clinical studies; Recruiting and enrolling clinical investigators and researchers to conduct clinical studies for clinical studies

Pharmaceutical consultation in the field of new specialty drugs; Providing information to patients in the field of administering medications; Providing medical information to patients; Patient healthcare counseling and advice regarding products in the field of prescription drugs; Providing medical information in the field of adherence and compliance to prescribed medication dosing regimens and disease state for prescribers, patients, and the pharmaceutical and/or medical device industry by means of a call center; Collecting and reporting medical information about drugs or medical devices, namely, providing medical information about drug interaction and medical device interaction by means of call centers, providing medical information regarding adverse events regarding drugs and medical devices, and providing medical information about drugs and medical devices requested by medical providers; Direct response medical pre-screening services for clinical trials, pharmaceutical treatment, medical devices, and surgical procedures; Reviewing, abstracting, processing, and analyzing data from patient medical charts, namely, providing medical profiles and medical record analysis and assessments for medical purposes

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 4, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
May 4, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 30, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 29, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 4, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 1, 2021 AITU
USE AMENDMENT FILED
Feb 9, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 9, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 11, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2020 NONP
ASSIGNED TO LIE
May 12, 2020 ALIE
EXPARTE APPEAL TERMINATED
May 8, 2020 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 8, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 8, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 8, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 8, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 14, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 14, 2019 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 25, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 25, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 25, 2019 CNRT
EX PARTE APPEAL-INSTITUTED
Sep 23, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 23, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Sep 23, 2019 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 4, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 21, 2019 GNFN
FINAL REFUSAL E-MAILED
Mar 21, 2019 GNFR
FINAL REFUSAL WRITTEN
Mar 21, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 27, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 27, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 27, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 20, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 13, 2018 NWOS
NEW APPLICATION ENTERED
Apr 9, 2018 NWAP